Specifically, elevated expression levels of ATP11A, GBE1, and SOAT1 were associated with an increased risk of CRC (OR > 1), while increased expression of FAM120A, MCM6, MSRA, and ZDHHC4 was associated with a reduced risk (OR < 1). Here, ATP11A is linked to colorectal carcinoma.